CLINICAL_TRIALS
withdrawal
· 2024-11-07
Clinical Trial Update: Investigation of Flare and Remission in Subjects With Atopic Dermatitis [Phase 4]
Summary
A Phase 4 clinical trial investigating flare and remission in subjects with atopic dermatitis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 4 | Status: WITHDRAWN